These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8349777)

  • 1. Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.
    Pfaller MA; Barry AL; Fuchs PC
    J Clin Microbiol; 1993 Jul; 31(7):1924-6. PubMed ID: 8349777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility testing and resistance phenotypes detection in bacterial pathogens using the VITEK 2 System.
    Stefaniuk E; Mrówka A; Hryniewicz W
    Pol J Microbiol; 2005; 54(4):311-6. PubMed ID: 16599303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):305-9. PubMed ID: 10385024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A; Joseph J; Sharma S; Nutheti R; Garg P; Das T
    Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents.
    Biedenbach DJ; Jones RN
    J Clin Microbiol; 1997 Dec; 35(12):3198-202. PubMed ID: 9399519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.
    Sjölund-Karlsson M; Howie RL; Crump JA; Whichard JM
    J Clin Microbiol; 2014 Mar; 52(3):877-84. PubMed ID: 24391204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
    Noviello S; Ianniello F; Leone S; Esposito S
    Infez Med; 2006 Mar; 14(1):24-8. PubMed ID: 17405239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of "gram-sure" with vancomycin disks in distinguishing between gram-negative and gram-positive rods.
    Leonard RB; Ohlson S; Newcomb-Gayman PL; Carroll KC
    Am J Clin Pathol; 1995 Jul; 104(1):69-71. PubMed ID: 7611185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.
    Defife R; Scheetz MH; Feinglass JM; Postelnick MJ; Scarsi KK
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1074-9. PubMed ID: 19075047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
    Dholakia N; Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Antimicrob Agents Chemother; 1994 Apr; 38(4):848-52. PubMed ID: 8031057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
    Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.
    Cai T; Mazzoli S; Meacci F; Boddi V; Mondaini N; Malossini G; Bartoletti R
    J Microbiol; 2011 Jun; 49(3):448-54. PubMed ID: 21717331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.
    Kayser FH; Wüst J
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):163-6. PubMed ID: 2060516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin.
    Yamane N; Jones RN; Frei R; Hoban DJ; Pignatari AC; Marco F
    J Chemother; 1994 Apr; 6(2):83-91. PubMed ID: 8077990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H
    J Chemother; 2015 Feb; 27(2):124-5. PubMed ID: 25248022
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents.
    Cormican MG; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1995 Dec; 23(4):157-60. PubMed ID: 9407222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test.
    Madhusudhan KT; Counts C; Lody C; Carter O; Dodson S; Ojha N
    Chemotherapy; 2003 Jul; 49(4):184-8. PubMed ID: 12886053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 2000 Dec; 38(4):243-53. PubMed ID: 11146251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.